No Data
No Data
Sector Update: Health Care Stocks Rise in Thursday Trading
Top Midday Gainers
JonesTrading Maintains Monopar Therapeutics(MNPR.US) With Buy Rating, Maintains Target Price $9
Monopar Therapeutics Inc: Strong Buy Rating on Robust Clinical Advancements and Promising Therapeutic Trials
Wall Street Set to Open Slightly Higher as Investors Parse Employment, Inflation Data
Why Monopar Therapeutics (MNPR) Stock Is Skyrocketing Today
No Data
No Data
OneNightOnly : I hope you are right. I don't need 30. 10 would be good enough :)